Analyst: New Bavarian Nordic initiatives reflect soaring monkeypox vaccine demand
The Danish vaccine maker is showing signs of trying to meet rising demand for the monkeypox vaccine, and this can only be a good thing, according to a Sydbank analyst.
by marketwire, translated by daniel pedersen
The monkeypox outbreak has put pressure on Bavarian Nordic as the only company in the world with a vaccine against the disease.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
